Literature DB >> 7073270

Susceptibility of Shigella species to erythromycin.

R N Greenberg, R D Pearson, D J Innes, K T Sauer, L D Halterman, R L Guerrant.   

Abstract

Two of the most common causes of inflammatory enteritis are Campylobacter fetus subsp. jejuni and Shigella species. No single antimicrobial agent is recommended for treatment of both diseases. Erythromycin is used to treat C. fetus subsp. jejuni infections but has not been studied in shigellosis. For this reason, we determined the susceptibility of 22 strains of Shigella to erythromycin and found that Shigella species are susceptible to concentrations of erythromycin which are obtainable in stool.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7073270      PMCID： PMC181887          DOI： 10.1128/AAC.21.2.347

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Preoperative bowel preparation. Erythromycin base serum and fecal levels following oral administration.

Authors:  R L Nichols; R E Condon; A R DiSanto
Journal:  Arch Surg       Date:  1977-12

Review 2.  Campylobacter enteritis.

Authors:  J P Butzler; M B Skirrow
Journal:  Clin Gastroenterol       Date:  1979-09

3.  Inhibition of cell to cell transfer of Shigella by treatment with some antibiotics.

Authors:  Y Osada; T Une; H Ogawa
Journal:  Jpn J Microbiol       Date:  1973-05

4.  Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics.

Authors:  J P Butzler; P Dekeyser; T Lafontaine
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

5.  Clinical and bacteriological evaluation of antibiotic treatment in shigellosis.

Authors:  M J Tong; D G Martin; J J Cunningham; J J Gunning
Journal:  JAMA       Date:  1970-12-07       Impact factor: 56.272

6.  Method of reliable determination of minimal lethal antibiotic concentrations.

Authors:  R D Pearson; R T Steigbigel; H T Davis; S W Chapman
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

7.  Effects of cephalexin, erythromycin and clindamycin on the aerobic Gram-negative faecal flora in man.

Authors:  C L Hartley; H M Clements; K B Linton
Journal:  J Med Microbiol       Date:  1978-05       Impact factor: 2.472

8.  Campylobacter enteritis in children.

Authors:  M A Karmali; P C Fleming
Journal:  J Pediatr       Date:  1979-04       Impact factor: 4.406

9.  Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni.

Authors:  R Vanhoof; B Gordts; R Dierickx; H Coignau; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

10.  Value of examination for fecal leukocytes in the early diagnosis of shigellosis.

Authors:  O M Korzeniowski; F A Barada; J D Rouse; R L Guerrant
Journal:  Am J Trop Med Hyg       Date:  1979-11       Impact factor: 2.345
  10 in total
  2 in total

1.  Erythromycin-resistant Campylobacter infections in Thailand.

Authors:  D N Taylor; M J Blaser; P Echeverria; C Pitarangsi; L Bodhidatta; W L Wang
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

2.  Genome Analysis of a Historical Shigella dysenteriae Serotype 1 Strain Carrying a Conserved Stx Prophage Region.

Authors:  Domonkos Sváb; Linda Falgenhauer; Balázs Horváth; Gergely Maróti; Jane Falgenhauer; Trinad Chakraborty; István Tóth
Journal:  Front Microbiol       Date:  2021-01-08       Impact factor: 5.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.